First National Bank Of Hutchinson Maintains Position in Constellation Brands (STZ); Nationwide Fund Advisors Has Lifted Its Aerie Pharmaceuticals (AERI) Stake by $498,336

February 21, 2018 - By Pete Kolinski

First National Bank Of Hutchinson increased its stake in Constellation Brands Inc (STZ) by 99.23% based on its latest 2017Q3 regulatory filing with the SEC. First National Bank Of Hutchinson bought 1,540 shares as the company’s stock rose 13.40% with the market. The institutional investor held 3,092 shares of the beverages (production and distribution) company at the end of 2017Q3, valued at $616,000, up from 1,552 at the end of the previous reported quarter. First National Bank Of Hutchinson who had been investing in Constellation Brands Inc for a number of months, seems to be bullish on the $42.24B market cap company. The stock decreased 0.97% or $2.12 during the last trading session, reaching $217.33. About 1.02M shares traded. Constellation Brands, Inc. (NYSE:STZ) has risen 17.20% since February 21, 2017 and is uptrending. It has outperformed by 0.50% the S&P500.

Nationwide Fund Advisors increased its stake in Aerie Pharmaceuticals (AERI) by 16.96% based on its latest 2017Q3 regulatory filing with the SEC. Nationwide Fund Advisors bought 10,382 shares as the company’s stock declined 8.47% while stock markets rallied. The institutional investor held 71,609 shares of the health care company at the end of 2017Q3, valued at $3.48M, up from 61,227 at the end of the previous reported quarter. Nationwide Fund Advisors who had been investing in Aerie Pharmaceuticals for a number of months, seems to be bullish on the $2.13 billion market cap company. The stock decreased 1.28% or $0.7 during the last trading session, reaching $54.2. About 284,595 shares traded. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has risen 180.20% since February 21, 2017 and is uptrending. It has outperformed by 163.50% the S&P500.

Investors sentiment decreased to 1.14 in Q3 2017. Its down 0.02, from 1.16 in 2017Q2. It worsened, as 40 investors sold STZ shares while 242 reduced holdings. 79 funds opened positions while 243 raised stakes. 144.05 million shares or 0.63% more from 143.15 million shares in 2017Q2 were reported. Dimensional Fund Limited Partnership holds 0.04% or 458,122 shares in its portfolio. Sigma Planning Corporation holds 0.1% of its portfolio in Constellation Brands, Inc. (NYSE:STZ) for 6,214 shares. 223,534 are held by State Of Wisconsin Board. Moreover, Qs Investors Ltd Liability Company has 0.02% invested in Constellation Brands, Inc. (NYSE:STZ). Moreover, Strs Ohio has 0.36% invested in Constellation Brands, Inc. (NYSE:STZ). Fmr Ltd Llc holds 0.12% or 5.10 million shares. Bokf Na invested 0.01% in Constellation Brands, Inc. (NYSE:STZ). Tiemann Investment Advsrs Limited Co has invested 0.39% in Constellation Brands, Inc. (NYSE:STZ). Burney Co holds 24,194 shares or 0.31% of its portfolio. State Of Tennessee Treasury Department accumulated 0.36% or 359,510 shares. Metropolitan Life Insurance Ny owns 88,155 shares. Susquehanna Int Grp Ltd Liability Partnership has invested 0.01% of its portfolio in Constellation Brands, Inc. (NYSE:STZ). Yorktown Mgmt And Research Company owns 1,700 shares. New York-based M&T Fincl Bank Corporation has invested 0.03% in Constellation Brands, Inc. (NYSE:STZ). Atlas Browninc invested 0.12% of its portfolio in Constellation Brands, Inc. (NYSE:STZ).

Since August 23, 2017, it had 0 insider purchases, and 4 selling transactions for $12.05 million activity. $520,000 worth of Constellation Brands, Inc. (NYSE:STZ) was sold by FROMBERG BARRY A on Tuesday, October 10. Newlands William A also sold $616,644 worth of Constellation Brands, Inc. (NYSE:STZ) shares. $2.47M worth of Constellation Brands, Inc. (NYSE:STZ) shares were sold by Hackett William F..

Among 23 analysts covering Constellation Brands (NYSE:STZ), 16 have Buy rating, 0 Sell and 7 Hold. Therefore 70% are positive. Constellation Brands had 75 analyst reports since August 27, 2015 according to SRatingsIntel. The stock of Constellation Brands, Inc. (NYSE:STZ) earned “Outperform” rating by Cowen & Co on Tuesday, April 11. The firm has “Hold” rating by Credit Suisse given on Thursday, June 29. Wells Fargo maintained Constellation Brands, Inc. (NYSE:STZ) rating on Friday, June 30. Wells Fargo has “Buy” rating and $21500 target. The stock has “Buy” rating by Morgan Stanley on Friday, June 9. The firm earned “Buy” rating on Friday, October 2 by Argus Research. SunTrust maintained the stock with “Buy” rating in Thursday, October 6 report. Pivotal Research maintained Constellation Brands, Inc. (NYSE:STZ) rating on Thursday, January 7. Pivotal Research has “Buy” rating and $185.0 target. The firm has “Buy” rating by Argus Research given on Monday, January 11. The firm earned “Buy” rating on Friday, December 22 by Stifel Nicolaus. On Monday, June 26 the stock rating was maintained by Susquehanna with “Hold”.

First National Bank Of Hutchinson, which manages about $160.65M US Long portfolio, decreased its stake in Mettler Toledo International Inc (NYSE:MTD) by 642 shares to 1,271 shares, valued at $813,000 in 2017Q3, according to the filing.

Among 15 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 15 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 47 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cowen & Co given on Wednesday, August 2. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, September 15. Canaccord Genuity maintained Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) rating on Wednesday, September 20. Canaccord Genuity has “Buy” rating and $65.0 target. Cantor Fitzgerald maintained it with “Buy” rating and $40 target in Thursday, September 17 report. Cowen & Co maintained the stock with “Buy” rating in Thursday, November 9 report. Cantor Fitzgerald maintained it with “Buy” rating and $62.0 target in Wednesday, October 11 report. The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has “Buy” rating given on Thursday, July 20 by H.C. Wainwright. The firm has “Buy” rating given on Friday, June 3 by Cantor Fitzgerald. The firm has “Buy” rating given on Monday, December 18 by Cantor Fitzgerald. JMP Securities initiated Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) on Wednesday, September 9 with “Market Outperform” rating.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>